Jehyeong Yu

Jehyeong Yu

Auto-generated profile, based on publicly available information

Jehyeong Yu

Healthcare Data Science Center, Konyang University Hospital, Daejeon, Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2023 in Public Health
Verified
Journal Article
Open access
JKJong-Yeup Kim
Jong-Yeup Kim
JHJ.Y. Hong
J.Y. Hong
SKS.M. Kim
S.M. Kim
KRK.H. Ryu
K.H. Ryu
DKD.S. Kim
D.S. Kim
JLJ. Lee
J. Lee
This study aimed to explore socio-economic factors and medical conditions that affect regular stomach cancer (SC) screening among Korean adults. This was a retrospective observational study. Study subjects were 5545 adults aged ≥40 years who participated in the 2007-2012 Korean National Health and Nutrition Examination Survey and were followed up to year 2017 based on data linking to the Korean National Health Insurance Service and Korean Health Insurance Review and Assessment. Socio-economic factors included sex, age, residential area, education, occupation, marital status, disability, public and private health insurance, service through local public health organizations, history of cancer except for SC, and family history of SC. Medical factors included six gastric lesions with the possibility of facilitating SC screening, including benign gastric neoplasm, chronic atrophic gastritis, gastric polyp, Helicobacter pylori infection, intestinal metaplasia, and peptic ulcers. The outcome was adherence to SC screening, which was divided into non-adherence, irregular adherence, and regular adherence. After adjusting for the effects of socio-economic factors, multivariate ordinal logistic regression revealed that participants with a history of four types of gastric lesions were more likely to regularly participate in SC screening: chronic atrophic gastritis (odds ratio [OR] 1.567; 95% confidence interval [CI] = 1.276-1.923), gastric polyps (OR 1.565; 95% CI = 1.223-2.003), H. pylori infection (OR 1.637; 95% CI = 1.338-2.003), and peptic ulcer (OR 2.226; 95% CI 1.750-2.831). To improve participation in SC screening, it is necessary to implement personalized strategies for individuals at risk for gastric cancer in addition to population-based strategies for vulnerable groups.

1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
DKDae Sung Kim
Dae Sung Kim
JHJeeyoung Hong
Jeeyoung Hong
KRKi-Hyun Ryu
Ki-Hyun Ryu
SLSang Hyuk Lee
Sang Hyuk Lee
HCHwanhyi Cho
Hwanhyi Cho
JKJong-Yeup Kim
Jong-Yeup Kim
Kim DS, et al. J Korean Med Sci. 2024 Jan;39(4):e36. https://doi.org/10.3346/jkms.2024.39.e36

30 November 2022 in Journal of Health Informatics and Statistics
Verified
Journal Article
Open access
PDF file
JYJe-Hyeong Yu
Je-Hyeong Yu
SLSeunghee Lee
Seunghee Lee
JKJong-Yeup Kim
Jong-Yeup Kim
Ji Woong SonJi Woong Son
Ji Woong Son
GKGwan woo Ku
Gwan woo Ku
SLSuehyun Lee
Suehyun Lee
Objectives: This was a pilot study to investigate the possibility of clinical analysis to support the lack of sample size of real data and to generate synthetic data. Since real data has many limitations, such as ethical issues and costly issues, there have been many attempts to create realistic synthetic data. The focus is on whether synthetic data can be used instead of real data. Methods: This study analyzed 11,978 lung cancer patients who used anticancer drug therapy using synthetic data as a quasi-experimental study. Clinically significant variables were extracted and some tables containing patient status and treatment records were preprocessed. This experiment was applied to the propensity score matching technique to prevent the bias of covariates. Then, the preprocessed data were analyzed using Kaplan-Meier estimation and Cox proportional hazards model. Results: When plotting the survival curves, the curves from the synthetic data did not match the curves for the actual data of the other covariates. In Cohort 1, Gen I had a better 5-year OS than Gen II (S1=0.973, S2=0.953, p<0.05). Similarly, Gen I anti-cancer was better than Gen III in Cohort 2 (S1=0.990, S3=0.884, p< 0.05). In the exploratory sub-group analysis using the Cox regression model, the risk ratio was estimated. We found that Gen I had a better effect on hazard ratio than Gen II and III. However, those results were different from the actual trend. Conclusions: It was found that the analysis based on the DATA-FREE-BOX data was different from the trend of the survival analysis conducted with the real data. The trend of this analysis could be different from the real trend. It will be able to contribute to data-validation. Moreover, it is expected that the same methodology can be applied in clinical studies based on actual data by utilizing the technique used in this study.